Impact of XDEMVY ® on Demodex Blepharitis in Soft Contact Lens Wearers
Conditions: Demodex Blepharitis Interventions: Drug: Lotilaner ophthalmic solution, 0.25%; Drug: Vehicle control Sponsors: Tarsus Pharmaceuticals, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 25, 2023 Category: Research Source Type: clinical trials
Safety and Efficacy of ST-100 (Vezocolmitide) Ophthalmic Solution 60 μg/ml Ophthalmic Solution in Subjects Diagnosed With Dry Eye Disease (DED)
Conditions: Dry Eye Disease Interventions: Drug: ST-100 (vezocolmitide); Drug: Vehicle Sponsors: ORA, Inc.; Stuart Therapeutics, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 21, 2023 Category: Research Source Type: clinical trials
A Randomized, Open-label, Active-controlled, Phase 2a Clinical Trial to Evaluate the Efficacy and Safety of TFC-003 in Patients With Primary Open-angle Glaucoma or Ocular Hypertension
Conditions: Primary Open Angle Glaucoma; Ocular Hypertension Interventions: Drug: TFC-003; Drug: COSOPT ophthalmic solution Sponsors: Kukje Pharma Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 20, 2023 Category: Research Source Type: clinical trials
Widefield Confocal Scanning Laser Ophthalmoscope Optimized for Pediatric and Neonatal Imaging
Conditions: Eye Diseases Interventions: Device: WiSLO; Device: Volk Pictor Plus ™ Sponsors: Duke University; National Eye Institute (NEI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 20, 2023 Category: Research Source Type: clinical trials
Azura Ophthalmics Announces Positive Results from Phase 2 Clinical Trial of AZR-MD-001 in Patients with Contact Lens Discomfort
Study met its primary endpoint and showed significant and clinically meaningful improvements in multiple symptoms of Contact Lens Discomfort and signs of concomitant Meibomian Gland Dysfunction
Patients in the AZR-MD-001 arm gained at least three... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - December 18, 2023 Category: Pharmaceuticals Source Type: clinical trials
BroadBand Light for the Treatment of Dry Eye Disease
Conditions: Dry Eye Syndromes; Meibomian Gland Dysfunction Interventions: Device: Broadband Light treatment; Device: Sham broadband light treatment Sponsors: University of Southern California; Ophthalmic Surgeons& Consultants of Ohio, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 18, 2023 Category: Research Source Type: clinical trials
Low Dose Atropine for Symptomatic Vitreous Floaters
Conditions: Vitreous Floaters Interventions: Drug: 0.01% atropine ophthalmic drop Sponsors: Jeanette Du Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 18, 2023 Category: Research Source Type: clinical trials
An Exploratory Study of Visual Function Rehabilitation in Patients With Ocular Trauma
Conditions: Eye Injuries Interventions: Device: Perceptual Learning Sponsors: Zhongshan Ophthalmic Center, Sun Yat-sen University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 18, 2023 Category: Research Source Type: clinical trials
Study of the Efficacy and Safety of OCS-01 Eye Drops in Subjects With Diabetic Macular Edema (DIAMOND-2)
Conditions: Diabetic Macular Edema Interventions: Drug: Dexamethasone ophthalmic suspension (OCS-01); Drug: Vehicle Sponsors: Oculis; ICON plc Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 15, 2023 Category: Research Source Type: clinical trials
Adaptive Optics ScanningLaser Ophthalmoscope Safety and Efficacy Clinical Trial
Conditions: Retinal Disease; Healthy Interventions: Other: No intervention measures Sponsors: Robotrak Technologies Co., Ltd. Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 15, 2023 Category: Research Source Type: clinical trials
Phase 2: VVN461 Ophthalmic Solution for Post -Operative Ocular Inflammation After Cataract Surgery
Conditions: Ocular Inflammation in Subjects Undergoing Cataract Surgery Interventions: Drug: VVN461 Ophthalmic Solution 1.0%; Drug: VVN461 Ophthalmic Solution 0.5%; Drug: Vehicle Sponsors: VivaVision Biotech, Inc Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 11, 2023 Category: Research Source Type: clinical trials
Management of the Ocular Surface With Preservative-Free Lubricants in Patients With Dry Eye
Conditions: Dry Eye Disease Interventions: Drug: Preservative-free sterile ophthalmic solution, with 0.3% propylene glycol and 0.4% polyethylene glycol (400) Sponsors: Tecnoquimicas Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 8, 2023 Category: Research Source Type: clinical trials
Safety, Tolerability, and Distribution of Topical Laquinimod Eye Drops : a Phase 1 Study
Conditions: Uveitis Interventions: Drug: Laquinimod eye drops Sponsors: Quan Dong Nguyen; Global Ophthalmic Research Center (GORC) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 7, 2023 Category: Research Source Type: clinical trials
Eyelid Androgen Treatment in Dry Eye
Conditions: Aqueous Tear Deficiency; Meibomian Gland Dysfunction of Bilateral Eyes (Disorder) Interventions: Drug: Testosterone gel 4.5%; Drug: Vehicle gel Sponsors: Southern California College of Optometry at Marshall B. Ketchum University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 4, 2023 Category: Research Source Type: clinical trials
Phase 2 Trial Evaluating Travoprost Ophthalmic Topical Cream in Subjects With Open-angle Glaucoma or Ocular Hypertension
Conditions: Open Angle Glaucoma; Ocular Hypertension Interventions: Drug: Travoprost Ophthalmic Topical Cream low-dose; Drug: Travoprost Ophthalmic Topical Cream mid-dose; Drug: Travoprost Ophthalmic Topical Cream high-dose; Drug: Timolol maleate ophthalmic solution, 0.5%; Drug: Travoprost Ophthalmic Solution, 0.004% Sponsors: Glaukos Corporation Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 1, 2023 Category: Research Source Type: clinical trials
